186 related articles for article (PubMed ID: 17074350)
1. Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters.
Yildiz BO; Goodarzi MO; Guo X; Rotter JI; Azziz R
Fertil Steril; 2006 Dec; 86(6):1688-93. PubMed ID: 17074350
[TBL] [Abstract][Full Text] [Related]
2. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
3. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
[TBL] [Abstract][Full Text] [Related]
4. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
Kjøtrød SB; Sunde A; von Düring V; Carlsen SM
Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
[TBL] [Abstract][Full Text] [Related]
5. Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters.
Goodarzi MO; Guo X; Yildiz BO; Stanczyk FZ; Azziz R
Am J Obstet Gynecol; 2007 Apr; 196(4):398.e1-5; discussion 398.e5-6. PubMed ID: 17403434
[TBL] [Abstract][Full Text] [Related]
6. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
7. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
Vural B; Ozkan S; Bodur H
J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
[TBL] [Abstract][Full Text] [Related]
8. Myostatin and its association with abdominal obesity, androgen and follistatin levels in women with polycystic ovary syndrome.
Chen MJ; Han DS; Yang JH; Yang YS; Ho HN; Yang WS
Hum Reprod; 2012 Aug; 27(8):2476-83. PubMed ID: 22693174
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.
Kjøtrød SB; Romundstad P; von Düring V; Sunde A; Carlsen SM
Fertil Steril; 2008 Mar; 89(3):635-41. PubMed ID: 17548076
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome.
Carlsen SM; Vanky E; Fleming R
Hum Reprod; 2009 Jul; 24(7):1732-8. PubMed ID: 19342396
[TBL] [Abstract][Full Text] [Related]
11. [Serum levels of ghrelin and leptin in women with polycystic ovary syndrome].
Pekhlivanov B; Mitkov M; Orbtsova M; Terzieva D
Akush Ginekol (Sofiia); 2008; 47(3):15-9. PubMed ID: 18756827
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
Słopień R; Lewandowski K; Kolacz E; Zawilska K; Warenik-Szymankiewicz A
Gynecol Endocrinol; 2006 Nov; 22(11):651-4. PubMed ID: 17145652
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma visfatin concentrations in women with polycystic ovary syndrome.
Chan TF; Chen YL; Chen HH; Lee CH; Jong SB; Tsai EM
Fertil Steril; 2007 Aug; 88(2):401-5. PubMed ID: 17335820
[TBL] [Abstract][Full Text] [Related]
14. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
15. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
Mitkov M; Pehlivanov B; Orbetzova M
Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome.
Carmina E; Gonzalez F; Chang L; Lobo RA
Obstet Gynecol; 1995 Jun; 85(6):971-6. PubMed ID: 7770269
[TBL] [Abstract][Full Text] [Related]
18. Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome.
Goodarzi MO; Antoine HJ; Azziz R
J Clin Endocrinol Metab; 2007 Jul; 92(7):2659-64. PubMed ID: 17426092
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups.
Chang WY; Knochenhauer ES; Bartolucci AA; Azziz R
Fertil Steril; 2005 Jun; 83(6):1717-23. PubMed ID: 15950641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]